1. Contractors
  2. Seegene USA, Inc.

Seegene USA, Inc.

Federal contractor · In-Vitro Diagnostic Substance Manufacturing

Seegene USA has 1 federal contract of $100,000 or more active since October 2023, with $122K obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
1 since FY2024$121,950 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
Centers for Disease Control and Prevention$122K on 1 contract
UEI
YDDKWNE9JAY7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
Eo 14398: Novaplex SystemCenters for Disease Control and Prevention · 75D30126P21232$121,950Jun 14, 2027in 6 monthsCA

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
Centers for Disease Control and Prevention1 contract$121,950

What they sell

IndustryAmount
In-Vitro Diagnostic Substance ManufacturingNAICS 325413 · 1 contract$121,950

Where the work is

Place of workAmount
California1 contract$121,950

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at Centers for Disease Control and Prevention: see the list.

Get new notices like Seegene USA's work

New contract opportunities under NAICS 325413, in-vitro diagnostic substance manufacturing, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy